Company intelligence / Profile preview

Medsteer

Suresnes, Ile-de-France, France

Ownership: Private
Development stage: Other

Overview

Medsteer is a leader in closed-loop anesthetic delivery systems. Its proprietary EasyTIVA platform utilizes AI-based algorithms and real-time patient feedback (EEG/Bispectral Index) to automate the co-administration of propofol and remifentanil. The technology has been clinically validated in over 25 settings and more than 15,000 patients. In 2026, Medsteer entered a strategic partnership with Cyclerion Therapeutics to integrate its technology into the CYC-126 program for treatment-resistant depression, which is advancing toward a Phase 2 proof-of-concept study.

Therapeutic areas: PsychiatryNeurologyOther
Modalities: DeviceSmall moleculeAI-based drug delivery
Industry: Therapeutic Medical Devices

Partnerships

Cyclerion TherapeuticsMedtronicGE Healthcare

Beyond the preview

Go deeper on Medsteer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medsteer.

Explore the full profile